Literature DB >> 2685710

Evaluation of tumor regression and other prognostic factors for early and late metastasis after proton irradiation of uveal melanoma.

R J Glynn1, J M Seddon, E S Gragoudas, K M Egan, L J Hart.   

Abstract

The authors examined the relationship of change in tumor height after proton beam irradiation with the risk of metastasis in 700 patients treated for uveal melanoma before July 1, 1986. Rates of change in tumor height were computed for each patient using follow-up ultrasonographic measures during the first 2 years after treatment. Risk of metastasis was evaluated separately in the first 2 years after treatment when tumor decline was assessed (concurrent metastasis), and 2 years or later after treatment (subsequent metastasis). Using Cox proportional hazards models to adjust for other known risk factors, tumors regressing rapidly were significantly more likely to metastasize concurrently with their regression (P less than 0.05). The opposite was found for subsequent metastasis: tumors with a slow annual decline were more likely to metastasize after 2 years after treatment (P less than 0.05). Substantial changes also were noted in the ability of previously described prognostic factors (largest tumor diameter, tumor height, ciliary body involvement, and patient's age) to predict early and late metastasis. Characteristics placing individuals at high risk of metastasis may change markedly with time after treatment.

Entities:  

Mesh:

Year:  1989        PMID: 2685710     DOI: 10.1016/s0161-6420(89)32685-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  13 in total

1.  A randomized, controlled trial of varying radiation doses in the treatment of choroidal melanoma.

Authors:  E S Gragoudas
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  Tumor-height regression rate after brachytherapy between choroidal melanoma gene expression profile classes: effect of controlling for tumor height.

Authors:  Kishan Gupta; Colin A McCannel; Mitchell Kamrava; James Lamb; Robert D Almanzor; Tara A McCannel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-02-24       Impact factor: 3.117

3.  Gene expression profiling and regression rate of irradiated uveal melanomas.

Authors:  Rajesh C Rao; Mehnaz Khan; Shahed N Badiyan; J William Harbour
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2015-03       Impact factor: 1.300

4.  Uveal melanoma: molecular pattern, clinical features, and radiation response.

Authors:  Michael C Chappell; Devron H Char; Tia B Cole; J William Harbour; Kavita Mishra; Vivian K Weinberg; Theodore L Phillips
Journal:  Am J Ophthalmol       Date:  2012-04-27       Impact factor: 5.258

5.  Uveal Melanoma Regression after Brachytherapy: Relationship with Chromosome 3 Monosomy Status.

Authors:  Sachin M Salvi; Hassan A Aziz; Suhail Dar; Nakul Singh; Brandy Hayden-Loreck; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2016-10-29

6.  Risk factors for metastatic uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

7.  Combined iodine-125 plaque irradiation and indirect ophthalmoscope laser therapy of choroidal malignant melanomas: comparison with iodine-125 and cobalt-60 plaque radiotherapy alone.

Authors:  J J Augsburger; M Kleineidam; D Mullen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-09       Impact factor: 3.117

8.  Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma.

Authors:  I Kaiserman; I Anteby; I Chowers; E Z Blumenthal; I Kliers; J Pe'er
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

Review 9.  The effectiveness and safety of proton radiation therapy for indications of the eye : a systematic review.

Authors:  Geertruida E Bekkering; Anne W S Rutjes; Vasiliy V Vlassov; Daniel M Aebersold; Konrade von Bremen; Peter Jüni; Jos Kleijnen
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

10.  Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival.

Authors:  S L Smith; B E Damato; A G M Scholes; J Nunn; J K Field; J Heighway
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.